SCHEMBL6180122

SCHEMBL6180122

COc1ccc(-c2noc(C(C)C(=O)O)c2-c2ccc(S(N)(=O)=O)cc2)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.45
CYP2C19 P33261 1/20 0.45
HSP90AA1 P07900 3/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
PTGS2 P35354 7/20 0.41
CA2 P00918 9/20 0.40
CA9 Q16790 9/20 0.40
CA1 P00915 8/20 0.40
CA12 O43570 7/20 0.40
CA4 P22748 6/20 0.40
CA7 P43166 2/20 0.40
CA14 Q9ULX7 2/20 0.40
PTGS1 P23219 3/20 0.40
MT-CO2 P00403 1/20 0.39
LMNA P02545 1/20 0.39
CA3 P07451 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4888027 0.83 PTGS2 (0.50) PTGS2CA2CA9CA1CA12
SCHEMBL6180126 0.81 PTGS2 (0.49) PTGS2PTGS1PDE3A
SCHEMBL4884123 0.78 PTGS2 (0.64) PTGS2CA2CA9CA1CA12
SCHEMBL9124523 0.76 PTGS2 (0.59) PTGS2PTGS1PDE3A
SCHEMBL8474574 0.75 CA1 (0.48) APPAKR1C3AKR1C2PTGS2CA2
SCHEMBL6168007 0.73 PTGS2 (0.53) PTGS2CA2CA9CA1CA12
SCHEMBL8474584 0.72 PTGS2 (0.59) PTGS2CA2CA9CA1CA12
SCHEMBL6168376 0.70 MEN1 (0.40) CYP2C19AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL6168516 0.69 PTGS2 (0.55) PTGS2CA4PTGS1
SCHEMBL8474484 0.69 CA1 (0.46) PTGS2CA2CA9CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed